Multinational firms call for innovative drug price reform

Korea is already being recognized for its excellent clinical research and drug development infrastructure, world-class researchers, hospitals and facilities. It is already one of the leading countries in clinical trial tests.

Despite these advantages, experts say Korea needs to implement more pro-innovation policies to encourage growth in the sector.

“Korea has the potential, but under th...